Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Melanoma treatment details. Chemotherapy. University of Texas MD Anderson Cancer Center, Houston, TX, United States

Survival: 12.0 months
Toxicity Grade: 3
Treatments: Chemotherapy
Drugs: Trisenox
Country: United States
City/State/Province: Houston, TX
Hospital: University of Texas MD Anderson Cancer Center
Journal: Link
Date: 10/2005

Patients: This Phase II study involved 20 patients with metastatic melanoma, 13 men and 7 women.

Treatment: The treatment consisted of a form of chemotherapy, arsenic trioxide.

Toxicity: Grade 3 toxicities included neytopenia, fatigue, abdominal pain, and arthralgia.

Results: There were no responses and the median overall survival was 12 months (based on Figure 2 of the study).

Support: The study was supported by Cell Therapeutics. This company markets arsenic trioxide.

Correspondence: Agop Y. Bedikian, MD

E-mail to a Friend Email Physician More Information